Mick Correll

Sarah Cannon — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index2.1kcitations72works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(14), Chronic Lymphocytic Leukemia Research(13), Cancer-related molecular mechanisms research(9), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(8), Bioinformatics and Genomic Networks(8)

Publications72 total

Performance of point‐of‐care severity scores to predict prognosis in patients admitted through the emergency department with COVID‐19
Journal of Hospital Medicine·2023· 6 citedOpen Access
Data from Integrative Genomic Analysis Implicates Gain of <i>PIK3CA</i> at 3q26 and <i>MYC</i> at 8q24 in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of <i>PIK3CA</i> at 3q26 and <i>MYC</i> at 8q24 in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Methods, Figures 1-4 and Tables 1 - 5, 7 - 15 from Integrative Genomic Analysis Implicates Gain of <i>PIK3CA</i> at 3q26 and <i>MYC</i> at 8q24 in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of <i>PIK3CA</i> at 3q26 and <i>MYC</i> at 8q24 in Chronic Lymphocytic Leukemia
2023Open Access
Data from Integrative Genomic Analysis Implicates Gain of <i>PIK3CA</i> at 3q26 and <i>MYC</i> at 8q24 in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Methods, Figures 1-4 and Tables 1 - 5, 7 - 15 from Integrative Genomic Analysis Implicates Gain of <i>PIK3CA</i> at 3q26 and <i>MYC</i> at 8q24 in Chronic Lymphocytic Leukemia
2023Open Access
Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19
Journal of Clinical Investigation·2021· 47 citedOpen Access
Association of Convalescent Plasma Treatment with Reduced Mortality and Improved Clinical Trajectory in Patients Hospitalized with COVID-19 in the Community Setting
2021· 5 citedOpen Access
Development of a Real-Time Risk Model (RTRM) for Predicting In-Hospital COVID-19 Mortality
2021· 4 citedOpen Access
Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States
Clinical Transplantation·2021· 52 citedOpen Access
Clinical and genomic analysis of non-small cell lung cancer (NSCLC) patients with MET exon14 skipping (METex14) mutations and responses to anti-MET therapy.
Journal of Clinical Oncology·2020· 4 cited
Mutational analysis of >14,000 NGS tests from community oncology practices: The Sarah Cannon molecular landscape.
Journal of Global Oncology·2019Open Access
Mutational analysis of >14,000 solid tumor NGS tests from community oncology practices: The Sarah Cannon molecular landscape.
Journal of Clinical Oncology·2019
Identifying and interpreting actionable molecular alterations from next-generation sequencing results in the community: A Sarah Cannon molecular cancer conference.
Journal of Clinical Oncology·2018
Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies
Cancer Genetics·2017· 28 cited
Addition of Chromosomal Microarray and Next Generation Sequencing to FISH and Classical Cytogenetics Enhances Genomic Profiling of Myeloid Malignancies
Cancer Genetics·2017
A Proactively Developed and Curated Copy Number/Copy Neutral Loss of Heterozygosity Interpretation Database/System Across Multiple Neoplasms for Highly Informative and Timely Reporting in a High-Volume Laboratory
Cancer Genetics·2017
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia
Blood·2016· 27 citedOpen Access
Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors
Cancer Genetics·2016· 7 cited
page 1 of 4Next →

Frequent Co-authors

John Quackenbush(22), Yaoyu E. Wang(8), John Tedrow(8), Frank C. Sciurba(8), Avrum Spira(8), Naftali Kaminski(8), Jennifer R. Brown(8), Megan Hanna(8), Bethany Tesar(8), Lillian Werner(8), Laura E. MacConaill(8), Donna Neuberg(8), Arnold S. Freedman(8), Ivana V. Yang(7), Mark W. Geraci(7), Stacey M. Fernandes(7), Brenda Juan Guardela(6), Nathalie Pochet(6), Catherine J. Wu(6), Yves Van de Peer(6)